Thrilled to see our correspondence published in JCO! We highlight that LAPC requires individualized restaging to unlock the true surgical conversion potential of FOLFIRINOX. Congrats to the whole team! 🔬👏 @Orhunakdogan91 @DrOzanYazc1 @tubaugurdr https://t.co/C0LkPNLMDU

RT @Xesiloglu: Grateful to ESMO – European Society for Medical Oncology for the opportunity to join the Advanced Course on ADC Development…

When is enough enough? 🌈 5 years of complete remission on CDK4/6i. 5 years of neutropenia, fatigue, monthly visits. My patient asked the question we rarely ask: “Why continue if there’s no evidence I need to?” We spend years learning WHEN TO START therapy. But we rarely

AI-Driven Recurrence Detection in Clinical Cancer Research A shareable NLP model from @DanaFarber accurately identified breast and colorectal cancer recurrence from imaging reports with ~90% accuracy and <2-week median error — a scalable step toward automated real-world outcomes

Great first mentorship session with Dr. Michael J. Hall @doctormikehall from @FoxChaseCancer discussing hereditary cancer syndromes & GI genetics! Thanks to @ASCO for supporting young oncologists through the Virtual Mentorship Program 🌍 #ASCO #FoxChaseCancerCenter

Today is the day! @RyanNipp is one legend you don't want to miss as he summarizes #ASCOQLTY25 for @PallOncCoP. If you don't have the link, send us a message or get added to the listserv. @DanijelaJakovl9 @RichaThakurMD @RachelA104 @Dr_Butin @Mombada1 @DrAlisonW

🎯 Honored to present two posters at #ESMO25 Berlin! 🇩🇪 🧤 2854P – Neuro Glove: A prospective self-controlled study investigating glove compression as a protective strategy against chemotherapy-induced peripheral neuropathy in women with gynecologic malignancies. 🫁 2865P – LRF

Honored to present our recent studies at #ESMO2025! 🌍 Proud to contribute to 9 different oncology projects this year — integrating AI, digital health, and clinical oncology for better patient outcomes. Excited to continue expanding our multi-center collaborations and AI-driven

🎯 Proud to be at #ESMO25 with 9 accepted posters, representing Etlik City Hospital & Gazi University! Grateful to @myESMO for this valuable opportunity to share our work and contribute to the global oncology community — ESMO belongs to all of us. 🌍💙 @osutcuoglu @kbaskurtt

✨ Couldn’t imagine a better milestone to celebrate my first year in the oncology community — thank you, #ESMO! 💙 Honored to share my thoughts in this official #ESMO2025 video among inspiring colleagues from around the world 🌍🎥 #myESMOStory #Oncology #ESMO25 #CareerMilestones

🎬 Kicking off #ESMO25 with excitement! Had the pleasure of sharing my insights in a pre-congress interview. 💬 Presenting a project I’ve been dedicated to for the past two years makes this milestone truly special. 💫 You’re warmly invited to Poster Session 8 on Sunday – 🩺

Day 2 at #ESMO25 – Berlin 🇩🇪 A truly inspiring session with Dr. Mairéad McNamara and Dr. Banerjee — outstanding talks on advancing patient-centered oncology and translational impact. Grateful for the insightful discussions and the chance to learn from such leading experts. #ESMO

🌍 Great energy and inspiring moments at #ESMO2025! So glad to connect with Dr. Samuel Klempner & Dr. Elizabeth Smyth — truly inspiring talks on the future of GI oncology 🔬💬 #myESMOStory #ESMO #ESMO25 #Oncology #GIcancer #ESMOcommunity #ONEoncologycommunity #CareerMilestones

Proud to share our latest work published in Clinical Colorectal Cancer! 🧠 CINR-AI Study — We developed inflammation-, nutrition-, and sarcopenia-based AI models to predict pathological response after total neoadjuvant therapy (TNT) in locally advanced rectal cancer. Key

📣 Just published! Prognostic significance of liver-to-muscle FDG uptake ratio and inflammatory biomarkers in small cell lung cancer 📊 LRF SUVmean ratio emerged as a novel marker of metabolic frailty and survival. 🧠 A simple PET/CT-derived biomarker with strong prognostic

👉Our new @ESMO_Open paper just OUT! Check the risk of VTE of PARPi in our meta-analysis! @myESMO @OncoAlert @DrYukselUrun @DrChoueiri @Erman_Akkus @APCCC_Lugano @DrRanaMcKay #cancer #Oncology #MedX @neerajaiims @maxinesun @Silke_Gillessen @Ecastromarcos

📢 Just published in Cancer A randomized controlled trial in Brazil tested GAIN-S (geriatric assessment–guided supportive care) in older adults with metastatic cancer. 🔑 Key Findings: •Improved prognostic awareness in emotional & adaptive domains •Better coping with

Just in @JAMANetworkOpen 👉 In pt level data from two ph3 trials (n=2187) 👉statin use associated with ⬆️ OS in advanced #prostatecancer treated with apalutamide. Congrats @ziremozay and @Soum_Roy_RadOnc Free access👉 https://t.co/tCO0bidsBr @PCFnews @urotoday @OncoAlert

Our study tested GAIN-S in older adults w metastatic cancer 🇧🇷 ➡️ GAIN-S improved emotional + adaptive aspects of prognostic awareness vs usual care Full paper https://t.co/djRJXf5lnX Thanks to @WilliamDale_MD @Areejmd @EnriqueSoto8 @PauloBergerot @RyanNipp